Indeed, elevated pro-inflammatory cytokines such as C-reactive protein (CRP), interleukin (IL)-6, including lipid peroxidation makers, such as malondialdehyde (MDA) levels, have been identified in patients with dyslipidemia [13,14,15]. This evidence concerns the gene IL6 and metabolic syndrome.